Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.119 CHF
463.71 M CHF
18.08 B CHF
199.03 M
About FRESEN.MED.CARE KGAA O.N.
Sector
Industry
CEO
Helen Giza
Website
Headquarters
Bad Homburg
Founded
2006
ISIN
DE0005785802
FIGI
BBG006TLQ0F3
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
F
FMS5184425
Fresenius Medical Care US Finance III, Inc. 3.0% 01-DEC-2031Yield to maturity
5.73%
Maturity date
Dec 1, 2031
F
US35805BAA61
FreMedCarUSFin3 3,75% 15/06/2029 Rule 144AYield to maturity
5.67%
Maturity date
Jun 15, 2029
F
FMS5184423
Fresenius Medical Care US Finance III, Inc. 1.875% 01-DEC-2026Yield to maturity
5.64%
Maturity date
Dec 1, 2026
Explore more bonds
Frequently Asked Questions
The current price of FME is 41.449 CHF — it has increased by 20.56% in the past 24 hours. Watch FRESENIUS MEDICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange FRESENIUS MEDICAL stocks are traded under the ticker FME.
FME stock has risen by 20.56% compared to the previous week, the month change is a 20.56% rise, over the last year FRESENIUS MEDICAL has showed a 14.21% increase.
We've gathered analysts' opinions on FRESENIUS MEDICAL future price: according to them, FME price has a max estimate of 48.52 CHF and a min estimate of 27.06 CHF. Watch FME chart and read a more detailed FRESENIUS MEDICAL stock forecast: see what analysts think of FRESENIUS MEDICAL and suggest that you do with its stocks.
FME stock is 17.10% volatile and has beta coefficient of 0.81. Track FRESENIUS MEDICAL stock price on the chart and check out the list of the most volatile stocks — is FRESENIUS MEDICAL there?
Today FRESENIUS MEDICAL has the market capitalization of 11.99 B, it has increased by 0.62% over the last week.
Yes, you can track FRESENIUS MEDICAL financials in yearly and quarterly reports right on TradingView.
FRESENIUS MEDICAL is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
FME earnings for the last quarter are 0.77 CHF per share, whereas the estimation was 0.67 CHF resulting in a 15.40% surprise. The estimated earnings for the next quarter are 0.83 CHF per share. See more details about FRESENIUS MEDICAL earnings.
FRESENIUS MEDICAL revenue for the last quarter amounts to 4.55 B CHF, despite the estimated figure of 4.67 B CHF. In the next quarter, revenue is expected to reach 5.11 B CHF.
FME net income for the last quarter is 201.00 M CHF, while the quarter before that showed 180.10 M CHF of net income which accounts for 11.60% change. Track more FRESENIUS MEDICAL financial stats to get the full picture.
Yes, FME dividends are paid annually. The last dividend per share was 1.18 CHF. As of today, Dividend Yield (TTM)% is 2.71%. Tracking FRESENIUS MEDICAL dividends might help you take more informed decisions.
FRESENIUS MEDICAL dividend yield was 3.13% in 2023, and payout ratio reached 69.97%. The year before the numbers were 3.66% and 48.77% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 23, 2024, the company has 119.84 K employees. See our rating of the largest employees — is FRESENIUS MEDICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FRESENIUS MEDICAL EBITDA is 3.00 B CHF, and current EBITDA margin is 16.45%. See more stats in FRESENIUS MEDICAL financial statements.
Like other stocks, FME shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FRESENIUS MEDICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FRESENIUS MEDICAL technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FRESENIUS MEDICAL stock shows the buy signal. See more of FRESENIUS MEDICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.